Sinem Nedime SÖKÜCÜ, Ahmet Levent KARASULU, Sedat ALTIN, Levent DALAR

Endobronşiyal kapakçık ile ilk deneyimlerimiz:Akciğer hacim azaltılmasında yeni bir yöntem

Endobronşiyal kapakçık, amfizemli hastalarda solunum fonksiyonu ölçümlerini ve yaşam kalitesini artırabilir. Kapakçık amfizemli akciğerin etkilenen kısmında inspiratuvar hava akımını bloke etmek için tasarlanmış olup, seçilmiş hastalarda akciğer hacim küçültücü cerrahisinin (AHKC) faydasını majör cerrahinin riskini almadan sunar. Ayrıca AHKC uygulanamayan olgularda ya da akciğer nakli öncesi akciğerlerde fonksiyonel kazanım sağlamak için bir olanak sunar. Bu yazıda, medikal tedaviye rağmen semptomları ve fonksiyonel kısıtlanmaları devam eden, dispne atakları nedeni ile sık hastane yatışı olan, heterojen amfizemli dört olguda endobronşiyal kapakçık kullanımı ile ilgili deneyimimiz tartışıldı. Anahtar sözcükler:

Our initial experiences with endobronchial valve:A new approach for lung volume reduction

An endobronchial valve can improve lung function measures and quality of life for patients with emphysema. The valve is designed to block inspiratory airflow in affected regions of an emphysematous lung, thereby conferring the benefits of lung volume reduction surgery (LVRS) without the risks of major surgery in selected patients. Also, it gives an option to improve lung functions in patients who are not candidates for LVRS or before transplantation. In this article, we discussed our experience on the use of endobronchial valves on four patients with heterogenous emphysema with persistent symptoms and functional restrictions, despite medical treatment and were frequently hospitalized due to dyspnea. Key words:

PDF

___

1. Fishman A, Martinez F, Naunheim K, Piantadosi S, Wise R, Ries A, et al. A randomized trial comparing lung- volume-reduction surgery with medical therapy for severe emphysema. N Engl J Med 2003;348:2059-73.
2. Brenner M, Hanna NM, Mina-Araghi R, Gelb AF, McKenna RJ Jr, Colt H. Innovative approaches to lung volume reduction for emphysema. Chest 2004;126:238-48.
3. National Emphysema Treatment Trial Research Group. Patients at high risk of death after lung-volume-reduction surgery. N Engl J Med 2001;345:1075-83.
4. Yim AP, Hwong TM, Lee TW, Li WW, Lam S, Yeung TK, et al. Early results of endoscopic lung volume reduction for emphysema. J Thorac Cardiovasc Surg 2004;127:1564-73.
5. Terry PB, Traystman RJ, Newball HH, Batra G, Menkes HA. Collateral ventilation in man. N Engl J Med 1978;298:10-5.
6. Aljuri N, Freitag L. Validation and pilot clinical study of a new bronchoscopic method to measure collateral ventilation before endobronchial lung volume reduction. J Appl Physiol 2009;106:774-83. doi: 10.1152/japplphysiol.91075.2008.
7. Wan IY, Toma TP, Geddes DM, Snell G, Williams T, Venuta F, et al. Bronchoscopic lung volume reduction for end-stage emphysema: report on the first 98 patients. Chest 2006;129:518-26.
8. Hopkinson NS. Bronchoscopic lung volume reduction: indications, effects and prospects. Curr Opin Pulm Med 2007;13:125-30.
9. Strange C, Herth FJ, Kovitz KL, McLennan G, Ernst A, Goldin J, et al. Design of the Endobronchial Valve for Emphysema Palliation Trial (VENT): a non-surgical method of lung volume reduction. BMC Pulm Med 2007;7:10.
10. de Oliveira HG, Macedo-Neto AV, John AB, Jungblut S, Prolla JC, Menna-Barreto SS, et al. Transbronchoscopic pulmonary emphysema treatment: 1-month to 24-month endoscopic follow-up. Chest 2006;130:190-9.